Radiochemoimmunotherapy
2025-SR-275
Phase 2 other active
Quick answer
Radiochemoimmunotherapy for Gastric Cancer is a Phase 2 program (other) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Gastric Cancer
- Phase
- Phase 2
- Modality
- other
- Status
- active